BorgWarner reports Q2 results on July 30 with the short side now rebuilding sharply — a direct reversal of the covering trend described just two days ago — while options traders remain near their most defensive stance of the past year.
The short interest picture has changed materially since Sunday's earnings preview. Shorts had been retreating through most of July, with SI falling as low as 3.1% of the free float around July 20–22. That cover trade has unwound fast: SI jumped roughly 37% over the past week to 4.2% of float, nearly back to the elevated levels seen in late June. The rebuild happened in a single session — shares short leapt from around 6.6 million on July 22 to over 9 million by July 24 and held there. Borrow costs ticked up 32% on the week to 0.45%, though that still leaves them well below the year's highs. Availability remains extraordinarily loose at over 4,500% — the lending pool is barely touched — so the fresh short interest reflects a deliberate directional bet, not a forced position. Positioning has shifted from cautious-but-covering to cautious-and-rebuilt in the span of a few sessions.
Options tell a consistent story. The put/call ratio eased marginally to 0.70 from a 52-week high of 0.72 hit earlier in the week, but remains well above its 20-day average of 0.61 — about one standard deviation elevated. The defensive tilt arrived quickly: the PCR was below 0.50 as recently as mid-July. Put demand has stayed elevated even as shorts were rebuilding, which means the two hedging instruments are now pointing in the same direction heading into tomorrow's print. That is a more charged setup than the divergence flagged on Sunday.
The Street is broadly constructive but not uniformly so. Barclays raised its target to $83 earlier this month, maintaining Overweight, and UBS upgraded to Buy in June with a $95 target — the most bullish call on the name. JPMorgan and Wells Fargo also sit at Overweight, though Morgan Stanley holds at Equal-Weight with a $67 target. The consensus mean sits around $77, roughly 22% above the current price of $63.21, which has now slipped about 7% over the past month. Valuation multiples have compressed alongside: the PE has drifted down to around 11.4x over the past 30 days, and EV/EBITDA sits near 6.7x — not stretched, but the forward earnings growth score ranks in the 82nd percentile, suggesting the Street is pricing in a recovery that has yet to show up in the multiple. The bull case centres on EV component exposure and cost discipline; bears point to powertrain headwinds and the pace of ICE revenue erosion.
Insiders have been consistent net sellers over the past 90 days — CEO Joseph Fadool sold just under $2 million in mid-May, accompanied by a cluster of VP-level disposals totalling several million dollars. None of the trades carry high significance scores, and they occurred into a period of relative strength when the stock was trading above $65, so they read more as routine realisation than a bearish signal. The institutional base is stable, with BlackRock holding over 13% and the top five holders collectively above 30%.
After the last two earnings events, the stock moved modestly on day one — roughly flat to up 1.6% the following session — but the five-day reaction was more meaningful, with the most recent Q1 print in May generating a 17% gain in the week after. The February print delivered a 5% five-day loss. Tomorrow's report is therefore less about the single-day reaction and more about whether management's guidance on EV revenue conversion and margin trajectory can justify the rebuild in short positions — or accelerate the covering trade that was already underway.
See the live data behind this article on ORTEX.
Open BWA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
